Author name: Dr. Rathod Medical Foundation

GI tumours can be treated without surgery in selected cases using endoscopic resection, ablation, stenting, and targeted systemic therapy. The approach depends on tumour location, depth of invasion, histology, and whether the intent is curative or palliative. Early-stage cancers and many benign tumours are now managed entirely through the scope, with surgery reserved for cases where endoscopic options aren’t suitable. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Surgery used to be the answer for most GI tumours. Now it’s the answer for some. The shift came from accurate staging with EUS, advanced endoscopic resection techniques like ESD, and the ability to ablate or stent lesions through the scope. Patients who would have had gastrectomy or oesophagectomy a decade ago now go home the next day after endoscopic treatment. The trick is choosing the right patient for the right approach.” What endoscopic options exist for GI tumours? The toolkit has expanded considerably. Different techniques serve different tumour types and locations. Endoscopic mucosal resection: Removes small superficial polyps and early cancers by injecting under the lesion and snaring it. Standard for small colorectal polyps and selected early gastric lesions. Submucosal dissection takes larger lesions out in one intact piece using an electrosurgical knife. Used for early gastric cancer, Barrett’s neoplasia, and large colorectal lesions where en bloc removal is essential. Radiofrequency ablation: Burns away dysplastic mucosa in Barrett’s oesophagus and similar conditions. Preserves the underlying organ while eliminating the abnormal tissue layer. Stenting handles malignant obstruction. Self-expanding metal stents reopen blocked oesophagus, stomach outlet, bile duct, or colon in advanced cancer, allowing symptom relief and continued chemotherapy. The choice depends on staging accuracy. Advanced endoscopy services that combine EUS, NBI, and the full range of resection techniques in one centre avoid the gap where patients are sent to surgery because the original assessment didn’t identify them as candidates for endoscopic treatment. When is endoscopic treatment definitive and when is it palliative? The distinction between curative and palliative intent shapes the entire treatment plan. Curative endoscopic resection: Early-stage cancers confined to the mucosa or superficial submucosa, without lymph node involvement, can be cured by complete removal alone. Long-term outcomes match surgery in selected cases. Ablation works for dysplastic lesions in Barrett’s oesophagus and other premalignant conditions. RFA and cryotherapy eliminate abnormal tissue and prevent progression to invasive cancer. Palliative stenting and debulking: Advanced cancers blocking the GI lumen are relieved by stent placement, allowing the patient to eat, swallow, or pass stool while systemic treatment continues. Bridging treatment in patients waiting for surgery or chemotherapy. Endoscopic stenting or biliary drainage stabilises the patient until definitive treatment can be delivered, particularly useful in obstructive jaundice from pancreatic head cancer. Patient selection separates good outcomes from poor ones. Read more on cancer staging for one of the central techniques in modern endoscopic cancer management. Why choose Dr. Vipulroy Rathod for endoscopic tumour treatment? Dr. Vipulroy Rathod has been performing advanced endoscopic resection and ablation at Fortis Hospital Mulund since the late 1990s. EMR. ESD. RFA. Stenting. EUS-guided procedures. Volumes that few centres in India can match under one roof, alongside multidisciplinary input from surgery and oncology that complex cases require. The judgment in tumour management isn’t always about the procedure. It’s about staging accurately, choosing the right approach, and recognising the cases where surgery genuinely is the better option rather than pushing endoscopic treatment that won’t deliver cure. Getting that call right depends on volume, experience, and honest assessment. Book your consultation today with one of India’s most experienced specialists for endoscopic tumor assessment and treatment. Book Appointment Call now Frequently Asked Questions Can all GI cancers be treated endoscopically? No, only early-stage cancers confined to the mucosa or superficial submucosa, without lymph node involvement, are candidates for curative endoscopic resection. Advanced cancers need surgery or systemic treatment. How is staging done before treatment? EUS for depth assessment, CT or MRI for distant spread, biopsy for histology, and sometimes PET scan in selected cases. The staging determines whether endoscopic treatment is appropriate. What is the recovery after endoscopic tumour resection? Most patients go home within twenty-four to forty-eight hours and return to normal activity within a week. Will I need follow-up after endoscopic treatment? Yes, surveillance endoscopy at three to six months initially, then yearly, is standard after endoscopic resection of cancer to detect any recurrence or new lesions at the earliest stage. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.

Double balloon endoscopy (DBE) is a specialised endoscopic technique that uses two balloons to advance a long scope deep into the small intestine, reaching areas that standard upper GI endoscopy and colonoscopy cannot access. It allows both diagnosis and therapy in the small bowel, including biopsy, bleeding control, polyp removal, and stricture dilatation, in a region previously accessible only through surgery. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “The small bowel used to be a blind spot. Standard scopes reach the duodenum and the terminal ileum, but the middle three to five metres in between were inaccessible without surgery. DBE changed that. Now we can scope the entire small bowel, take biopsies, treat bleeding, remove polyps, dilate strictures. Conditions that needed laparotomy a generation ago are managed through the scope alone.” What is double balloon endoscopy used for? DBE is used when small bowel pathology is suspected and other tests haven’t confirmed the diagnosis or location. Obscure GI bleeding. The commonest indication. Patients with recurrent bleeding where upper and lower endoscopy have been negative often have a small bowel source that DBE can find and treat in the same session. Small bowel Crohn’s disease for diagnosis, biopsy, and treatment of strictures with balloon dilatation. DBE allows direct visualisation and tissue sampling without surgical access. Small bowel tumours and polyps. Detection and removal of polyps in conditions like Peutz-Jeghers syndrome, neuroendocrine tumours, and isolated small bowel adenomas that capsule endoscopy has identified but couldn’t biopsy. Foreign body retrieval and complications of previous surgery. DBE handles cases involving retained surgical material, anastomotic strictures, and altered anatomy where other approaches have failed. The procedure is technically demanding and takes longer than standard endoscopy. Advanced endoscopy centres with DBE capability and the volume to maintain operator skill are still relatively limited in India, which means access depends on referral patterns and local availability. How is DBE performed and what is recovery like? The procedure uses a long enteroscope with an overtube, both fitted with inflatable balloons that grip the bowel wall during insertion. Antegrade or retrograde approach: DBE can be performed through the mouth to reach the proximal small bowel, or through the rectum to reach the distal small bowel, depending on the suspected lesion location. The scope and overtube are advanced alternately, with the balloons inflated and deflated in sequence to pull the bowel up over the scope rather than pushing the scope through the bowel. Therapeutic interventions during the same procedure: Biopsy, polypectomy, argon plasma coagulation for bleeding, balloon dilatation, and tattooing of lesions for surgical reference can all be performed without a second procedure. Recovery is similar to standard endoscopy, with patients usually going home the same day. Some abdominal discomfort and bloating for twenty-four to forty-eight hours is normal because of air insufflation during the procedure. DBE is one of the more demanding endoscopic procedures and the learning curve is significant. Read more on third space endoscopy for related advanced techniques that have expanded what endoscopy can achieve without surgery. Why choose Dr. Vipulroy Rathod for double balloon endoscopy? Dr. Vipulroy Rathod has been performing advanced enteroscopy and small bowel endoscopic procedures at Fortis Hospital Mulund for over three decades, including DBE for obscure GI bleeding, small bowel polyps, and Crohn’s disease assessment. The training and equipment requirements for DBE are significant, and the volume of small bowel cases handled in the unit allows for proper case selection and procedure planning. The judgment in small bowel endoscopy isn’t only about technical skill. It’s about deciding which patient genuinely needs DBE versus which patient is better served by capsule endoscopy first, surgery, or simply continued observation. Inappropriate use of DBE adds risk without changing management. Proper case selection is what makes the procedure worthwhile. Book your consultation today with one of India’s most experienced specialists for double balloon endoscopy and small bowel disease assessment. Book Appointment Call now Frequently Asked Questions How long does a DBE procedure take? Anywhere from one to three hours depending on the depth of insertion needed and whether therapy is performed. Antegrade approaches are usually faster than retrograde ones. Is DBE safer than surgery for small bowel disease? Yes in most cases. DBE avoids open or laparoscopic surgery and recovery is much faster, though complications like perforation, bleeding, and pancreatitis do occur in a small percentage of cases. What is the difference between DBE and capsule endoscopy? Capsule endoscopy is a diagnostic tool only and produces images but cannot biopsy or treat. DBE allows both visualisation and intervention, which is why it often follows a positive capsule study. Is DBE widely available in India? Limited. Only a small number of centres perform DBE at the volume needed to maintain operator expertise and offer the procedure as a routine service. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.

Narrow band imaging (NBI) is an advanced endoscopic technique that uses filtered blue and green light to highlight mucosal vessel and surface patterns, allowing detection of early cancers and precancerous lesions that standard white light endoscopy can miss. The technology is built into modern endoscopes and is switched on at the touch of a button during routine procedures. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “NBI changed how we look at the GI tract. The same scope, the same patient, but the lesions that white light barely shows light up clearly under NBI. Subtle Barrett’s dysplasia. Early gastric cancer in a chronic gastritis background. Flat colonic adenomas that would have been missed. It doesn’t replace careful inspection, but it makes careful inspection much more productive.” What does NBI show and how does it work? NBI works on the principle that haemoglobin absorbs specific wavelengths of light, which makes blood vessels appear with high contrast against surrounding tissue. Mucosal vessel patterns. NBI highlights the superficial capillary network on the mucosal surface. Early cancers produce irregular, distorted, or dense vessel patterns that stand out clearly from normal background mucosa. The pit pattern of glandular structures becomes more visible under NBI, which helps distinguish neoplastic from non-neoplastic lesions in the colon and stomach. Classifications like the Kudo and NICE systems are based on these patterns. Demarcation lines around lesions. NBI shows sharp borders between abnormal and normal mucosa more clearly than white light, which helps in deciding where the lesion ends and where the resection margin should be placed. Subtle colour changes from normal pink mucosa to brownish or whitish areas are amplified under NBI, particularly in the oesophagus where Barrett’s dysplasia and squamous neoplasia present as colour shifts before forming a visible mass. NBI is most useful when combined with high-definition endoscopy and magnification. Endoscopy services using modern scopes with NBI capability allow careful targeted inspection of high-risk areas rather than relying on random biopsies alone, which is the older approach to screening for early disease. Where is NBI most useful clinically? NBI has the strongest evidence base in a few specific clinical situations where early cancer detection changes management. Barrett’s oesophagus surveillance. NBI improves detection of dysplasia in Barrett’s patients, allowing targeted biopsies of visible lesions rather than random four-quadrant biopsies of normal-looking mucosa. Early gastric cancer screening in patients with chronic atrophic gastritis or intestinal metaplasia. NBI with magnification picks up subtle lesions that look unremarkable under white light. Colorectal polyp characterisation. NBI helps distinguish hyperplastic from adenomatous polyps in real time, reducing unnecessary polypectomy and allowing optical diagnosis in selected cases. Squamous cell oesophageal cancer in high-risk patients, particularly heavy smokers and drinkers. NBI lights up flat brownish areas that suggest early squamous neoplasia. NBI improves detection but it doesn’t replace endoscopic experience and time spent inspecting. Read more on Colon cancer screening for how NBI fits into the broader screening strategy across different GI cancer types. Why choose Dr. Vipulroy Rathod for NBI endoscopy? Dr. Vipulroy Rathod has been performing advanced endoscopy at Fortis Hospital Mulund for over three decades, with modern NBI-capable systems and the volume of cases that builds the pattern recognition NBI requires to be useful. The technology only adds value when the operator knows what they’re looking for, which is why NBI training matters as much as equipment availability in any centre. The mistake some centres make is assuming NBI alone improves cancer detection. It doesn’t. NBI improves detection when used by experienced operators who do careful targeted inspection. In less experienced hands, the additional information gets overlooked or misinterpreted, which is part of why NBI uptake has been slower than expected in many countries despite the supporting evidence. Book your consultation today with one of India’s most experienced specialists for NBI endoscopy and early GI cancer detection. Book Appointment Call now Frequently Asked Questions Is NBI a separate procedure or part of regular endoscopy? Part of regular endoscopy. NBI is built into modern scopes and switched on during the procedure at the operator’s discretion. Does NBI involve any extra preparation? No. The preparation for NBI endoscopy is the same as for any standard upper GI endoscopy or colonoscopy. Can NBI replace biopsies? In selected cases yes, particularly for small colorectal polyps where optical diagnosis is supported by current guidelines. For most other situations, biopsy remains the standard for tissue confirmation. Is NBI available in most Indian hospitals? Increasingly available in larger centres and tertiary hospitals, though not yet universal. Patients should ask whether the centre uses NBI-capable scopes for surveillance and high-risk screening procedures. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.

Endoscopic submucosal dissection (ESD) is an advanced endoscopic technique that removes early-stage GI cancers, large polyps, and submucosal lesions in a single intact piece through the scope. The procedure uses a specialised electrosurgical knife passed through a standard endoscope, allowing en bloc resection of lesions up to several centimetres in size without open or laparoscopic surgery. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “ESD is what changed the management of early GI cancer. Lesions that needed gastrectomy or oesophagectomy can now be removed through a scope, in one piece, with the patient going home the next day. The key is en bloc resection. That gives the pathologist a complete specimen and tells us whether the cancer was confined to the mucosa or has gone deeper, which decides whether anything else needs to follow.” What conditions are treated with ESD? ESD is reserved for lesions where en bloc resection is essential, mainly early cancers and large or complex polyps. Early gastric cancer. Tumours confined to the mucosa or superficial submucosa, without lymph node involvement, are the classic ESD indication. Cure rates match surgical resection in selected cases. Early oesophageal cancer including squamous cell carcinoma and Barrett’s adenocarcinoma in superficial stages. ESD provides definitive treatment while preserving the oesophagus completely. Large colorectal polyps and laterally spreading tumours. Lesions over 20 mm or those with features suggesting they can’t be safely removed by piecemeal EMR. ESD allows complete en bloc removal regardless of size. Submucosal tumours and certain neuroendocrine tumours in selected locations and sizes. ESD or tunnelling techniques remove these without breaching the muscle layer or needing surgery. The decision to do ESD depends on pre-procedure imaging assessment. Advanced endoscopy units with chromoendoscopy and EUS for accurate depth assessment select the right cases for ESD, distinguishing them from the lesions that need surgery instead. How is ESD performed and what is recovery like? The procedure uses a specialised electrosurgical knife and follows a structured sequence of marking, injection, incision, and dissection. Marking the margins. The borders of the lesion are marked with electrocautery dots, usually with a five-millimetre margin around visible disease. This defines the resection field. A submucosal injection lifts the lesion away from the muscle layer underneath, creating a working space. The solution is often mixed with dye to make the submucosal layer easier to see during dissection. Circumferential incision and dissection. The mucosa is incised along the marked margin, then the submucosal layer is dissected away from the muscle using the knife, freeing the lesion in one piece. Mucosal defect closure with clips at the end of the procedure. Most patients go home within twenty-four to forty-eight hours with normal activity resumed in a few days. ESD has a learning curve and complication rates fall sharply with operator experience. Read more on endoscopic procedures for related advanced submucosal techniques used in different clinical situations. Why choose Dr. Vipulroy Rathod for ESD? Dr. Vipulroy Rathod has been performing advanced endoscopic resection techniques at Fortis Hospital Mulund for over three decades, including ESD for early GI cancers and large lesions that would otherwise require surgical resection. The training and equipment requirements for ESD are significant, and the procedure is performed at only a small number of centres in India with the volume needed to do it safely. The reason ESD needs experienced hands is the dissection itself. The plane between the submucosa and muscle is narrow and the consequences of going wrong are serious. Perforation, bleeding, incomplete resection. The complication rate falls dramatically with operator experience, which is why ESD volume per operator matters more than equipment availability in any centre. Book your consultation today with one of India’s most experienced specialists for ESD and advanced endoscopic resection. Book Appointment Call now Frequently Asked Questions Is ESD as effective as surgery for early GI cancer? Yes, in appropriately selected cases. Cure rates match surgical resection when the lesion is correctly staged and the resection achieves clear margins. How long does an ESD procedure take? Anywhere from one to four hours depending on the size and location of the lesion. Large gastric ESDs and complex colorectal lesions take longer than smaller superficial cases. What are the main risks of ESD? Bleeding, perforation, and incomplete resection are the principal complications. All three are uncommon in experienced hands and most can be managed endoscopically when they occur. Is ESD available across India? Limited. Only a small number of centres offer ESD with the equipment and volume needed for safe practice. Most patients are referred to high-volume specialist units. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.

Third space endoscopy is a category of advanced endoscopic procedures that work in the submucosal layer of the GI tract, between the mucosa and the muscle wall, to treat conditions previously requiring surgery. It includes peroral endoscopic myotomy (POEM) for achalasia, submucosal tumour resection, and Zenker’s diverticulum repair. The approach uses the same scope used for routine endoscopy with specialised tools. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Third space endoscopy is one of the bigger shifts in GI procedural medicine over the last fifteen years. Conditions that needed open chest surgery or laparoscopy can now be treated through the scope alone. Achalasia. Submucosal tumours. Zenker’s diverticulum. Patients walk in the morning and walk out the same day. The recovery is dramatically shorter, the cosmetic result is invisible, and the outcomes match surgery in most published series.” What conditions are treated with third space endoscopy? The technique applies to a defined set of conditions where surgical access to the muscle layer is needed but the mucosa above can be preserved. Achalasia. Peroral endoscopic myotomy (POEM) cuts the lower oesophageal sphincter muscle through a submucosal tunnel. Replaces Heller myotomy in most appropriate cases, with similar long-term outcomes and faster recovery. Submucosal tumours like gastrointestinal stromal tumours (GISTs) and leiomyomas in the oesophagus, stomach, or duodenum. These can be respected through endoscopic submucosal dissection or tunnelling techniques without open surgery. Zenker’s diverticulum. A pharyngeal pouch causing dysphagia and regurgitation can be treated with Z-POEM, cutting the cricopharyngeal muscle endoscopically and avoiding open neck surgery. Gastroparesis with refractory symptoms. G-POEM (pyloromyotomy) cuts the pylorus muscle endoscopically, improving gastric emptying in patients who haven’t responded to medical management. The technique has expanded rapidly across centres in the last decade. Advanced endoscopy services with the equipment and training to perform third space procedures are still limited in India, which means access depends heavily on which centre a patient is referred to. How is third space endoscopy performed? The procedure uses a working channel and specialised electrosurgical knives passed through a standard endoscope. The anatomy of the submucosal space is what makes the technique possible. Submucosal injection. A solution is injected under the mucosa to create a working space between the mucosa and the muscle layer underneath. This separates the layers and reduces injury risk during cutting. A small mucosal incision is made several centimetres proximal to the target area, then a tunnel is dissected underneath through the submucosal space until the area of interest is reached. Targeted treatment. Depending on indication, the muscle layer is cut for myotomy, the tumour is dissected free, or the diverticular septum is divided. The treatment is precise and limited to the target structure. Mucosal closure at the entry point with endoscopic clips. This seals the submucosal tunnel from the lumen and allows healing without leak in the vast majority of cases. Recovery is short and the cosmetic result is invisible because there’s no incision through the skin. Read more on advanced GI procedures for related advanced endoscopic techniques used in complex GI conditions. Why choose Dr. Vipulroy Rathod for third space endoscopy? Dr. Vipulroy Rathod has been performing advanced endoscopic procedures at Fortis Hospital Mulund for over three decades, with experience in submucosal techniques, POEM, and the broader range of third space endoscopy procedures that few Indian centres can offer at volume. The training and equipment requirements are significant, which is part of why access to these procedures remains limited despite their proven benefits in the patient groups who need them. The decision to undergo a third space procedure isn’t only about which condition the patient has. It’s about whether the centre doing the procedure has the volume, the equipment, and the experience to handle the case safely and to manage complications if they arise. Patients should ask about case numbers before agreeing to any third space procedure. Book your consultation today with one of India’s most experienced specialists for advanced endoscopic procedure assessment and treatment. Book Appointment Call now Frequently Asked Questions Is third space endoscopy painful? The procedure itself is done under general anaesthesia or deep sedation and patients don’t feel it. Some chest or abdominal discomfort for a day or two afterwards is normal and settles on its own. How long is recovery? Most patients go home within twenty-four to forty-eight hours after the procedure, with normal activity resumed within a week. The recovery is significantly shorter than surgical alternatives for the same conditions. Is POEM as good as Heller myotomy for achalasia? Outcomes are similar in published series and meta-analyses, with comparable long-term symptom relief and slightly different side-effect profiles, particularly regarding post-procedure reflux which is more common after POEM. Are these procedures available across India? Limited. Only a small number of centres offer third space endoscopy with the volume and equipment needed to do it safely. Most patients are referred to high-volume centres for these specific procedures. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.

ERCP and surgery are two different approaches to bile duct disease. ERCP is a minimally invasive endoscopic procedure that accesses the bile duct through the mouth and duodenum, used for stone extraction, stricture dilatation, stent placement, and biliary drainage. Surgery is reserved for cases where ERCP has failed, where the underlying disease is surgically resectable, or where biliary reconstruction is required after major duct injury. Most bile duct problems are now managed endoscopically. Surgery becomes the answer only when endoscopy can’t reach or can’t fix what needs fixing. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Patients hear bile duct problems and assume surgery is next. For most conditions, that’s no longer true. ERCP handles stones, strictures, leaks, and drainage. Surgery still has a role, but it’s reserved for the cases ERCP can’t manage rather than the default. Getting that order right matters because surgery in this area carries real risk.” ERCP vs Surgery at a glance Factor ERCP Surgery Approach Through a scope Open or laparoscopic Recovery One to two days Two to four weeks Anaesthesia Sedation, short General, prolonged Use today First-line treatment Reserved for failed cases When is ERCP the right approach? ERCP handles most bile duct problems through endoscopic access alone, without any incision. Common bile duct stones: The classic indication for ERCP. Stones are removed using basket or balloon extraction after sphincterotomy, often in a single session, with success rates above ninety-five percent. Benign biliary strictures from chronic pancreatitis, primary sclerosing cholangitis, or post-surgical scarring. ERCP allows balloon dilatation and stent placement, often with repeated sessions over months until the duct stays open. Bile leaks after cholecystectomy: ERCP with sphincterotomy and stent placement closes most post-operative bile leaks without further surgery, with the stent removed once healing is confirmed. Malignant biliary obstruction from pancreatic cancer, cholangiocarcinoma, or other tumours. Stent placement relieves jaundice and prevents cholangitis, allowing chemotherapy to proceed in patients unfit for surgery. ERCP is the first-line approach for most bile duct problems today. Pancreatic and biliary stone extraction services that combine ERCP with EUS for difficult anatomy avoid the gap where patients are sent to surgery prematurely because standard ERCP access wasn’t possible. When is surgery still necessary? Surgery hasn’t been replaced by ERCP entirely. Specific indications still require operative management. Failed ERCP access: Altered surgical anatomy, large impacted stones, or technical failure of standard cannulation may require surgical exploration of the bile duct. EUS-guided rendezvous has reduced this group considerably but not eliminated it. Resectable bile duct cancer: Cholangiocarcinoma and gallbladder cancer with surgical cure intent need formal resection, not endoscopic palliation. The decision between resection and stenting depends on staging. Major bile duct injury after surgery: Significant disruption of the bile duct, usually after laparoscopic cholecystectomy, often needs surgical reconstruction with Roux-en-Y hepaticojejunostomy rather than endoscopic management. Complications of ERCP: Perforation, severe bleeding not controlled endoscopically, or recurrent strictures that have failed multiple dilatation attempts may require surgical revision in selected cases. The surgical group is smaller today than it was twenty years ago. Read more on how biliary stones are treated endoscopically for a closer look at one of the conditions where endoscopic management has largely replaced surgical reconstruction. Why choose Dr. Vipulroy Rathod for bile duct management? Dr. Vipulroy Rathod has been performing ERCP at Fortis Hospital Mulund since the late 1990s, with experience across stone extraction, stricture dilatation, leak management, biliary stenting, and the EUS-guided rendezvous procedures that get into ducts when standard ERCP can’t. The volume of biliary endoscopy in the unit is among the highest in India, which matters because complication rates fall sharply with operator experience in this field. The judgment that matters most in bile duct disease is knowing when ERCP can handle it and when surgery is the better option. Pushing ERCP in cases that genuinely need surgery wastes time and adds risk. Sending patients to surgery when ERCP would have worked exposes them to a much bigger operation than necessary. Getting that call right comes from doing both kinds of cases at volume. Book your consultation today with one of India’s most experienced specialists for bile duct assessment and ERCP management. Book Appointment Call now Frequently Asked Questions Is ERCP safer than surgery? Generally yes in terms of immediate complications and recovery, but ERCP has its own risks including pancreatitis, bleeding, and perforation that need experienced hands to manage. Can all bile duct stones be removed by ERCP? Yes in the large majority of cases. Very large or impacted stones may need cholangioscopy with electrohydraulic lithotripsy first, with surgery reserved for the rare cases that fail even advanced endoscopic techniques. How long is recovery after ERCP?  Most patients go home the same day or the following morning, with normal activity resumed within two to three days. Surgery in comparison requires two to four weeks of recovery depending on the procedure. When should I see a specialist for bile duct problems?  Any patient with jaundice, recurrent cholangitis, suspected stones, or imaging showing duct dilatation should be assessed by a specialist with experience in both ERCP and surgical referral. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.

Recurrent gallstone attacks happen when stones in the gallbladder repeatedly block the cystic duct or migrate into the common bile duct, causing episodes of biliary colic, cholecystitis, or cholangitis. The underlying cause is usually unchanged anatomy and physiology, the same gallbladder, the same stones forming for the same reasons, with each attack carrying its own risk of complications. Definitive treatment is cholecystectomy, because medical management of attacks doesn’t address why the stones formed in the first place. Patients with recurrent episodes shouldn’t wait for the next one to plan surgery. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Patients often manage one or two gallstone attacks and wait, hoping the next one won’t come. It usually does. Each attack carries its own risk. Pancreatitis. Cholangitis. Gangrenous gallbladder. The mistake isn’t having stones. It’s waiting for the third or fourth episode to do something definitive, when surgery after the first attack would have prevented all the ones that followed.” What conditions drive recurrent gallstone attacks? The cause is rarely random. Specific patient factors, stone characteristics, and behavioural patterns drive the cycle. Multiple small stones. Small stones are more likely to migrate from the gallbladder into the cystic or common bile duct, causing repeated obstruction. Large solitary stones tend to stay put, but small ones travel. Female sex, age above 40, obesity, rapid weight loss, and pregnancy all raise the underlying risk of stone formation and recurrence. These factors don’t go away between attacks, so the gallbladder keeps producing stones at the same rate. Cholesterol supersaturation in bile. Most gallstones are cholesterol-based, formed when bile becomes oversaturated with cholesterol relative to bile salts and lecithin. The supersaturation continues after each attack unless the gallbladder is removed. Conditions like haemolysis, cirrhosis, ileal disease, and certain medications produce pigment stones rather than cholesterol stones. The underlying disease keeps driving stone formation regardless of how many attacks have been managed. The cycle continues until the gallbladder is removed. Pancreatic and biliary stone extraction services that combine ERCP for common bile duct stones with planned cholecystectomy avoid the gap where patients are managed for each attack separately while the underlying problem remains untreated. How are recurrent gallstone attacks treated definitively? Definitive treatment means removing the source. Symptom management treats the attack but not the cause. Laparoscopic cholecystectomy. The standard treatment for recurrent symptomatic gallstones. Removes the gallbladder along with all stones inside, preventing future attacks completely in the large majority of patients. ERCP with stone extraction is needed alongside surgery when stones have migrated into the common bile duct. The combination of ERCP followed by cholecystectomy is the standard approach for patients presenting with choledocholithiasis. Timing of surgery matters. Cholecystectomy during the index admission for cholecystitis or pancreatitis is now preferred over delayed surgery, with better outcomes and shorter overall recovery in most patient groups. Patients unfit for surgery may need percutaneous cholecystostomy as a temporary measure, with later interval cholecystectomy when fitness allows or long-term tube management in patients who can’t safely undergo any operation. Surgery prevents future attacks reliably in most patients. Read more on gallstone pancreatitis for one of the more serious complications of recurrent gallstones that can develop without warning when a stone migrates at the wrong moment. Why choose Dr. Vipulroy Rathod for recurrent gallstone management? Dr. Vipulroy Rathod has been managing recurrent gallstone disease at Fortis Hospital Mulund since the late 1990s, with coordinated care across gastroenterology and surgical teams that makes timely cholecystectomy possible for patients who arrive mid-flare. Many patients arrive after multiple admissions for biliary colic, cholangitis, or pancreatitis, when earlier surgery would have prevented the cumulative damage that built up across episodes. The mistake patients usually make is treating each attack as an isolated event rather than part of a pattern. Definitive surgery isn’t a last resort. It’s the appropriate treatment for recurrent symptomatic gallstones, with low complication rates and a high success rate when done laparoscopically in experienced hands. Book your consultation today with one of India’s most experienced specialists for recurrent gallstone assessment and treatment planning. Book Appointment Call now Frequently Asked Questions Can gallstones be dissolved with medication? Ursodeoxycholic acid dissolves some small cholesterol stones over many months, but stones usually return after stopping treatment. Surgery is more reliable. Does diet alone prevent recurrent attacks? No. Diet may reduce attack frequency in some patients, but the underlying stone formation continues regardless of dietary changes. Can I live without a gallbladder? Yes. Bile flows directly from the liver into the intestine after cholecystectomy, and most patients have no long-term symptoms. A small minority develop mild diarrhoea or bile acid malabsorption that responds to treatment. How urgent is surgery after a gallstone attack? Increasingly urgent. Current guidelines favour cholecystectomy during the index admission for cholecystitis or pancreatitis rather than delayed surgery weeks later, because outcomes are better and the risk of further attacks during the waiting period is real. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.

Gallbladder polyps are growths on the inner wall of the gallbladder, mostly benign and usually found incidentally on ultrasound. The concern is the small minority that can turn malignant or already contain cancer at the time of detection. Risk depends on size, age, presence of gallstones, and underlying conditions. Polyps under 10 mm in a young patient without other features rarely need anything beyond follow-up scans. Larger polyps, rapidly growing ones, or polyps in higher-risk patients usually need cholecystectomy. The judgment is in distinguishing which is which. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Most gallbladder polyps are benign. Cholesterol polyps. Inflammatory polyps. Hyperplasia. None of those turn into cancer. So why do we still recommend follow-up for every polyp found on a routine scan? Because the small percentage that are adenomatous look identical on imaging, and the only way to know which group a patient is in is serial monitoring with surgical referral for the ones that show concerning features.” What types of gallbladder polyps exist and which are concerning? Polyps fall into a few categories. Most are non-neoplastic and stay benign throughout life. Cholesterol polyps. The commonest type. Around sixty percent of gallbladder polyps fall into this category, made of cholesterol-laden cells, small and often multiple. No malignant potential and rarely cause symptoms. Are inflammatory polyps dangerous? Almost never. These form after chronic gallbladder inflammation, usually alongside gallstones or recurrent cholecystitis, and have no cancer risk in themselves. Adenomatous polyps. True neoplastic lesions with malignant potential. Rare but the ones that drive surgical decisions. Risk of malignancy rises sharply with size, particularly above 10 mm. Adenomyomatosis is wall thickening that mimics a polyp on ultrasound. Not actually a polyp but often picked up the same way. Benign in itself, with imaging confirmation needed to distinguish it from a true polyp. The features that change the workup are well-defined. Endoscopic ultrasound gives better resolution than transabdominal ultrasound for assessing polyp characteristics, particularly in lesions where the type isn’t clear and the size sits close to the surgical threshold. When should a gallbladder polyp be removed? The decision rests on a combination of size, growth, patient factors, and concerning imaging features rather than any single criterion. Size above 10 mm. The single most important risk factor. Polyps at this size carry significantly higher malignancy risk and most guidelines recommend cholecystectomy regardless of other factors. Growth on serial scans matters even in smaller polyps. A 6 mm polyp growing to 9 mm over a year often warrants surgery even though neither size alone would trigger the recommendation. Age above 50. Polyps in older patients carry higher malignant potential than equivalent-sized polyps in younger patients. The combined size and age threshold drops in this group. Other concerning features. Solitary polyp with broad base. Sessile rather than pedunculated morphology. Primary sclerosing cholangitis. Indian or East Asian ethnicity. Coexisting gallstones. Any of these raise the threshold for intervention. Most patients don’t meet criteria and simply need follow-up scans. Read more on gallstone disease management for how gallbladder pathology fits into the broader picture, particularly when polyps and stones coexist. Why choose Dr. Vipulroy Rathod for gallbladder polyp assessment? Dr. Vipulroy Rathod has been managing biliary disease at Fortis Hospital Mulund since the late 1990s. Routine cholecystectomy cases. Complex polyp risk stratification. EUS-based assessment of indeterminate lesions. The patients who arrive after being told their polyp warrants urgent surgery without proper risk stratification. The patients who arrive having been told it’s nothing when family history and ethnicity put them in a higher-risk category. Both groups end up in the same clinic with very different management plans. The judgment in gallbladder polyp management sits between two errors. Over-treat a benign cholesterol polyp and the patient gets unnecessary surgery. Under-treat a small adenomatous polyp that turns malignant over the following year and the consequences are far worse. Volume and proper imaging assessment are what keep both errors rare. Book your consultation today with one of India’s most experienced specialists for gallbladder polyp assessment and surveillance. Book Appointment Call now Frequently Asked Questions Are gallbladder polyps cancerous? Rare cases of gallbladder polyps are cancerous. How often should small polyps be monitored?  Polyps under 6 mm need ultrasound every six to twelve months for two to three years. After that, less frequently if size and morphology stay stable, and the surveillance can be relaxed further or stopped completely in low-risk patients with consistently unchanged scans over a longer follow-up period. Does ethnicity affect polyp risk?  Yes, Indian and East Asian patients carry higher malignant potential for the same polyp size. What surgery is done for gallbladder polyps?  Laparoscopic cholecystectomy  is done for gallbladder polyps Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.

Biliary strictures are narrowings of the bile duct that obstruct bile flow. They are treated endoscopically through ERCP using balloon dilatation, plastic or metal stent placement, and increasingly with EUS-guided drainage when ERCP can’t reach. The approach depends on whether the stricture is benign or malignant, where it sits, and how the patient has responded to previous interventions. Most cases are managed without surgery, though malignant strictures often need long-term stenting alongside chemotherapy, and benign post-surgical strictures may need months of progressive dilatation before the duct stays open. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Biliary strictures used to mean surgery. Now most cases are managed endoscopically. Balloon dilatation. Plastic stents. Fully covered metal stents. EUS-guided drainage when ERCP fails. Each option fits a specific clinical scenario, and choosing the right one upfront avoids the repeat procedures that come with the wrong choice.” What are the types of biliary strictures and what causes them? Strictures are classified as benign or malignant. The cause changes the approach and the duration of treatment. Benign post-surgical strictures. Most often follow cholecystectomy, liver transplant, or biliary surgery. Scar tissue develops at the anastomosis or injury site over months, causing progressive narrowing. Inflammatory strictures from chronic pancreatitis, primary sclerosing cholangitis, autoimmune cholangitis, and IgG4-related disease. These behave differently from post-surgical strictures and often need disease-specific treatment alongside endoscopy. Malignant strictures. Cholangiocarcinoma, pancreatic head cancer, gallbladder cancer, metastases compressing the bile duct. Often the first presentation is jaundice, and stenting relieves symptoms while allowing chemotherapy to start. Stones impacted in the bile duct cause functional strictures. These usually resolve once the stone is removed through ERCP, though long-standing impaction occasionally leaves residual narrowing that needs separate dilatation. The cause dictates the treatment plan. Pancreatic and biliary stone extraction services that combine stone removal with stricture assessment in the same ERCP session avoid repeat procedures and allow simultaneous management when both problems coexist, which they often do. How are biliary strictures treated endoscopically? Endoscopic management runs on a sequence of steps, starting with the least invasive option that controls the problem. Balloon dilatation. A balloon catheter passed through the scope to the stricture and inflated to a controlled diameter. First-line for many benign strictures, with multiple sessions over months sometimes needed before the duct stays open. Plastic stent placement keeps the duct open after dilatation. Standard for benign strictures, with multiple stents placed alongside each other to maximise lumen diameter. Exchanged every three to six months until response is stable. Fully covered self-expanding metal stents. Used in malignant strictures and increasingly in benign refractory cases. Stay in place longer than plastic stents and produce larger lumen diameter, though cost and removability considerations vary by case. EUS-guided biliary drainage. Reserved for cases where ERCP has failed, often due to altered surgical anatomy or duodenal obstruction. The duct is accessed directly through the stomach or duodenum under ultrasound guidance. Choosing between stent types and timing of exchanges is what separates successful from problematic outcomes. Read more on bile duct cancer for one of the more challenging causes of biliary stricture that often requires complex endoscopic management alongside oncology treatment. Why choose Dr. Vipulroy Rathod for biliary stricture management? Dr. Vipulroy Rathod has been doing biliary endoscopy at Fortis Hospital Mulund since the late 1990s. ERCP. EUS-guided drainage. Cholangioscopy. The difficult anatomy cases where standard approaches have already failed. Stricture management is one of the higher-volume areas of biliary endoscopy in the unit, with patients referred from across India and abroad for cases that haven’t responded to initial treatment elsewhere. The challenge in stricture management isn’t usually the first dilatation. It’s the longer-term plan. Choosing the right stent. Knowing when to exchange. Knowing when to escalate to metal stents or surgical referral. Getting that sequence right is what avoids years of repeat procedures and incomplete relief. Book your consultation today with one of India’s most experienced specialists for biliary stricture assessment and endoscopic management. Book Appointment Call now Frequently Asked Questions Are biliary strictures painful? Biliary strictures are often painful. The pain is typically a sharp or cramping ache in the upper right abdomen that can radiate to the back and right shoulder.  How long does endoscopic stricture treatment take? Most benign strictures need repeated procedures over six to twelve months. Malignant strictures are usually managed with longer-lasting metal stents, with exchanges every few months as needed. Can biliary stents stay in permanently? Plastic stents need exchange every three to six months because they block over time. Metal stents can stay longer, sometimes indefinitely in malignant cases where the patient’s overall trajectory means the stent is functionally a permanent fixture rather than a temporary measure, particularly in palliative cholangiocarcinoma and pancreatic cancer management. When is surgery needed for a biliary stricture? Surgery for a biliary stricture is typically reserved for cases where the narrowing is caused by a malignant tumor, the stricture is too severe to be managed by less invasive procedures, or non-surgical treatments have failed.  Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.

Bile duct cancer, also called cholangiocarcinoma, is a rare and aggressive malignancy of the cells lining the bile ducts. It can arise anywhere along the biliary tree, from inside the liver down to where the duct enters the duodenum. The classification follows location, intrahepatic, perihilar, distal. Most patients present late because the early disease is silent. Jaundice. Weight loss. Itching that won’t go away. By the time these appear, treatment options have already narrowed. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Cholangiocarcinoma is hard to catch early. The ducts sit deep in the abdomen. Imaging shows duct dilatation. Often it doesn’t show the tumour itself. Patients arrive having been worked up for hepatitis or gallstones for weeks before anyone thinks of cancer. By then, resectability has often already gone.” What are the types of cholangiocarcinoma and how do they present? Classification follows location along the biliary tree. Location dictates symptoms, workup, and what treatment is possible. Intrahepatic cholangiocarcinoma. Inside the liver. Often a liver mass on imaging done for something else. Perihilar is the commonest type. Sits at the junction where the right and left hepatic ducts join, also called a Klatskin tumour. Presents as painless obstructive jaundice when the tumour blocks bile flow, and is often the hardest type to fully resect because of the proximity to major vascular structures and the need for extensive liver and bile duct resection together. Distal cholangiocarcinoma. Lower bile duct as it passes through the pancreas. Mimics pancreatic head cancer in presentation, gets worked up the same way, and the Whipple procedure is the operation when resectable. Risk factors matter but only in a minority. Primary sclerosing cholangitis. Choledochal cysts. Chronic biliary infection. Hepatitis B and C. Most cases occur in patients without any identifiable risk factor at all, which is part of what makes early detection so difficult and why surveillance is currently limited to high-risk groups rather than the general population. The workup needs both imaging and tissue. Endoscopic ultrasound with fine-needle aspiration is often the only way to obtain tissue from perihilar and distal lesions, while ERCP with brush cytology or cholangioscopy adds diagnostic yield in selected cases. How is cholangiocarcinoma treated? Treatment hinges entirely on resectability. Surgery offers the only realistic cure, though most patients aren’t surgical candidates by the time they present. Surgery. Liver resection for intrahepatic, extended liver and bile duct resection for perihilar, Whipple for distal. Five-year survival twenty to forty percent depending on type and stage. Neoadjuvant chemotherapy with capecitabine and gemcitabine improves outcomes in selected resectable cases, particularly perihilar tumours, and is increasingly used as part of multidisciplinary planning rather than reserved for relapse, which represents a real shift in how this disease is approached in major centres over the past decade. Liver transplant. Highly selected early perihilar cases. Strict criteria. Palliative biliary stenting for unresectable disease. ERCP or EUS-guided stent placement relieves jaundice, prevents cholangitis, and lets patients tolerate chemotherapy. The cornerstone of palliative care alongside systemic gemcitabine-cisplatin treatment, which remains the backbone of medical management in this group. Most cholangiocarcinoma patients need coordinated input from surgery, oncology, and interventional endoscopy from the start. Read more on biliary stone extraction for how endoscopic biliary work fits into the broader management of bile duct disease. Why choose Dr. Vipulroy Rathod for cholangiocarcinoma management? Dr. Vipulroy Rathod has been doing endoscopic assessment, biliary drainage, and tissue diagnosis of cholangiocarcinoma at Fortis Hospital Mulund since the late 1990s. EUS-guided biopsy. ERCP with brush cytology. Percutaneous drainage when endoscopic access fails. The volume of difficult biliary work that builds skill in unusual presentations is hard to acquire in centres that see one or two cases a year. The reason cholangiocarcinoma needs experienced hands isn’t only the diagnosis. It’s the staging, the biliary drainage strategy, and the question of resectability that often hinges on imaging and EUS findings together. Getting any of those wrong sends the patient down the wrong pathway from the start. Book your consultation today with one of India’s most experienced specialists for cholangiocarcinoma assessment and biliary management. Book Appointment Call now Frequently Asked Questions What are the early signs of bile duct cancer? Painless jaundice. Itching. Dark urine. Pale stools. Unexplained weight loss. These are the commonest features at presentation, with the jaundice often being the trigger that finally brings the patient to medical attention after weeks of vaguer symptoms that had been attributed to something else. Is cholangiocarcinoma curable? Only with successful resection. How is bile duct cancer diagnosed? MRI cholangiopancreatography is the starting imaging investigation. EUS with biopsy gives tissue from perihilar and distal lesions. ERCP with brush cytology adds further yield, and CT staging completes the workup before any treatment decision is finalised. Can bile duct cancer be screened for?  Not generally. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.